Companion Animal Diagnostics Market Size, Share, Growth Analysis, By Technology(Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology), By Application(Clinical Pathology, Bacteriology, Virology, Parasitology), By Animal Type(Dogs, Cats, Others (Other companion animals comprise rabbits, birds), By End-User(Diagnostic Labs, Veterinary Hospitals, Clinics, Point-Of-Care), By Region - Industry Forecast 2024-2031

The market is consolidated in nature, with a variety of small and major enterprises present. Idexx and Zoetis accounted for more than half of the industry's revenue. IDvet, Heska Corporation, Virbac, and Neogen Corporation are among the other participants. To achieve a larger market share, market players regularly participate in strategic activities such as new product launches, geographical growth, technical developments, and mergers & acquisitions. 

For instance, In December 2021, NEOGEN acquired Genetic Veterinary Sciences, Inc., which enlarged NEOGEN Corporation's global genomics business. and In September 2021, Heska Corporation purchased Biotech Laboratories. This acquisition bolstered the company's rapid assay point of care diagnostics portfolio.

Companion Animal Diagnostics Market Top Player's Company Profiles

• IDEXX Laboratories, Inc.
• Zoetis Inc.
• Heska Corporation
• Thermo Fisher Scientific, Inc.
• Abaxis, Inc.
• Virbac SA
• VCA, Inc.
• IDVet
• NEOGEN Corporation
• bioMérieux SA
• Randox Laboratories Ltd.
• AniCell Biotech
• Bionote Inc.
• Bio-Rad Laboratories, Inc.
• Neogen Corporation
• Antech Diagnostics
• Bionote, Inc.
• Eurofins Scientific SE
• Animalytix LLC
• Advanced Animal Diagnostics

Companion Animal Diagnostics Market Recent Development

• In September 2022, Zoetis Inc. acquired Jurox, a privately held animal health firm that develops, produces, and markets a broad variety of veterinary pharmaceuticals for the treatment of livestock and companion animals. Jurox's headquarters are in Australia, with regional offices in New Zealand, the United States, Canada, and the United Kingdom. 
• In September 2022, Zomedica a veterinary health company that develops novel diagnostic and therapeutic solutions for companion animals, announced today the commercial introduction of its newest assay - Free T4 (fT4) - for the TRUFORMA In-Clinic Biosensor Testing Platform.
• In March 2022, Companion Animal Health, a division of DJO and a global animal health company specialising in laser and rehabilitation therapies and on-site diagnostics in veterinary markets worldwide, announced a strategic agreement with HT Bioimaging to co-brand and exclusively sell the HTVet product in the United States and Canada.